ArticleMemorias do Instituto Oswaldo Cruz2015
Atlas of Mexican Triatominae (Reduviidae: Hemiptera) and vector transmission of Chagas disease.
Article in Memorias do Instituto Oswaldo Cruz, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
45 citing papers in PubMed, 1 synthesis or guideline pooled it, 158 citations in OpenAlex.
- Estimating the current burden of Chagas disease in Mexico: A systematic review and meta-analysis of epidemiological surveys from 2006 to 2017.PLoS neglected tropical diseases · 2019Pooled it
- Bat-associated Trypanosoma diversity, geographic extension of known clades, and predominance of T. cruzi TcIV in a conserved tropical forest of southeastern Mexico.Parasitology research · 2026Article
- Range expansion of two Triatominae species in Oaxaca, Mexico: first report and molecular identification of Triatoma barberi and Triatoma dimidiata in the Cañada regionFIRST REVIEW ROUND - REVIEWERS' COMMENTSREVIEWERS' COMMENTS.Memorias do Instituto Oswaldo Cruz · 2026Article
- MaxEnt modeling and risk evaluation of chagas disease vectors in the domestic cycle of Hidalgo, Mexico.PLoS neglected tropical diseases · 2025Article
- First Report of the L925I kdr Mutation Associated with Pyrethroid Resistance in Genetically DistinctTropical medicine and infectious disease · 2025Article
- Biological and Molecular Characterization of FiveTropical medicine and infectious disease · 2025Article
- Hospesneotomae n. gen. of the Triatomini tribe presents a turnaround in the taxonomy of the Triatoma protracta species complex.Scientific reports · 2025Article
- Immunomodulatory effects of Triatoma dimidiata feces on Trypanosoma cruzi infection in a murine model.Revista do Instituto de Medicina Tropical de Sao Paulo · 2025Article
- Tumor-Suppressive Cross-Linking of Anti-International journal of molecular sciences · 2024Article
- Trapping Triatominae Bugs Using Mice-Baited Traps along the Peninsula of Baja California, Mexico.The American journal of tropical medicine and hygiene · 2024Article
- First report of mixed Trypanosoma cruzi discrete typing units infection in Triatoma phyllosoma in the peri-urban environment of Oaxaca, Mexico.Revista da Sociedade Brasileira de Medicina Tropical · 2024Article
- Comparison of Climate Change Scenarios ofTropical medicine and infectious disease · 2023Article
- Article
- Ecological Niche Modelling Approaches: Challenges and Applications in Vector-Borne Diseases.Tropical medicine and infectious disease · 2023Review
- Geometric morphometrics and ecological niche modelling for delimitation ofCurrent research in parasitology & vector-borne diseases · 2023Article
- First record of Triatoma longipennis, Usinger, 1939 (Hemiptera: Reduviidae: Triatominae) in Tecozautla, Hidalgo.Revista da Sociedade Brasileira de Medicina Tropical · 2023Article
- Genetic diversity in peridomiciliary populations of Triatoma mexicana (Hemiptera: Reduviidae: Triatominae) in central Mexico.Parasitology research · 2022Article
- Toward New Epidemiological Landscapes ofTropical medicine and infectious disease · 2022Article
- The IMD and Toll canonical immune pathways of Triatoma pallidipennis are preferentially activated by Gram-negative and Gram-positive bacteria, respectively, but cross-activation also occurs.Parasites & vectors · 2022Article
- A review of the taxonomy and biology of Triatominae subspecies (Hemiptera: Reduviidae).Parasitology research · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chagas disease is one of the most important yet neglected parasitic diseases in Mexico and is transmitted by Triatominae. Nineteen of the 31 Mexican triatomine species have been consistently found to invade human houses and all have been found to be naturally infected with Trypanosoma cruzi. The present paper aims to produce a state-of-knowledge atlas of Mexican triatomines and analyse their geographic associations with T. cruzi, human demographics and landscape modification. Ecological niche models (ENMs) were constructed for the 19 species with more than 10 records in North America, as well as for T. cruzi. The 2010 Mexican national census and the 2007 National Forestry Inventory were used to analyse overlap patterns with ENMs. Niche breadth was greatest in species from the semiarid Nearctic Region, whereas species richness was associated with topographic heterogeneity in the Neotropical Region, particularly along the Pacific Coast. Three species, Triatoma longipennis, Triatoma mexicana and Triatoma barberi, overlapped with the greatest numbers of human communities, but these communities had the lowest rural/urban population ratios. Triatomine vectors have urbanised in most regions, demonstrating a high tolerance to human-modified habitats and broadened historical ranges, exposing more than 88% of the Mexican population and leaving few areas in Mexico without the potential for T. cruzi transmission.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.